Related references
Note: Only part of the references are listed.A zinc-finger transcriptional activator designed to interact with the γ-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts
Andrew Wilber et al.
BLOOD (2010)
Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6
Jian Xu et al.
GENES & DEVELOPMENT (2010)
Lentiviral Vector Gene Therapy: Effective and Safe?
Derek A. Persons
MOLECULAR THERAPY (2010)
Amelioration of murine β-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both γ-globin and the MGMT drug-resistance gene
Huifen Zhao et al.
BLOOD (2009)
Ineffective erythropoiesis and thalassemias
Stefano Rivella
CURRENT OPINION IN HEMATOLOGY (2009)
Optimized Lentiviral Vector Design Improves Titer and Transgene Expression of Vectors Containing the Chicken β-Globin Locus HS4 Insulator Element
Hideki Hanawa et al.
MOLECULAR THERAPY (2009)
Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo
Ryan L. Boudreau et al.
MOLECULAR THERAPY (2009)
Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
Tamara I. Pestina et al.
MOLECULAR THERAPY (2009)
GENE THERAPY β-Thalassemia Treatment Succeeds, With a Caveat
Jocelyn Kaiser
SCIENCE (2009)
Advances in the allogeneic transplantation for thalassemia
Guido Lucarelli et al.
BLOOD REVIEWS (2008)
Physiological promoters reduce the genotoxic risk of integrating gene vectors
Daniela Zychlinski et al.
MOLECULAR THERAPY (2008)
Globin lentiviral vector insertions can perturb the expression of endogenous genes in β-thalassemic hematopoietic cells
Phillip W. Hargrove et al.
MOLECULAR THERAPY (2008)
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia
Annarita Miccio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future
M. Bhatia et al.
BONE MARROW TRANSPLANTATION (2008)
Lessons from Nature: microRNA-based shRNA libraries
Kenneth Chang et al.
NATURE METHODS (2006)
A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells
F Stegmeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High-level β-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells
S Imren et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia
H Hanawa et al.
BLOOD (2004)
Correction of a mouse model of sickle cell disease:: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells
DN Levasseur et al.
BLOOD (2003)
Bcl11b is required for differentiation and survival of αβ T lymphocytes
Y Wakabayashi et al.
NATURE IMMUNOLOGY (2003)
Bcl11a is essential for normal lymphoid development
PT Liu et al.
NATURE IMMUNOLOGY (2003)
The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number
DA Persons et al.
BLOOD (2003)
Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors
A Amoyal et al.
HEMOGLOBIN (2003)
Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells
S Imren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Development of virus vectors for gene therapy of β chain hemoglobinopathies:: flanking with a chromatin insulator reduces γ-globin gene silencing in vivo
DW Emery et al.
BLOOD (2002)
In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients
G Migliaccio et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood
H Hanawa et al.
MOLECULAR THERAPY (2002)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
Functional requirements for phenotypic correction of murine β-thalassemia:: implications for human gene therapy
DA Persons et al.
BLOOD (2001)
Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias
DJ Weatherall
NATURE REVIEWS GENETICS (2001)
Ineffective erythropoiesis in β-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage
LA Mathias et al.
EXPERIMENTAL HEMATOLOGY (2000)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
Share Paper
